A Study to Assess the Effect of Food on the Bioavailability of Mebendazole From a Fast-Disintegrating Chewable Formulation of Mebendazole in Healthy Participants

NCT02051738 ↗

Phase 1 Completed 1 enrolled Janssen Research & Development, LLC

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to evaluate the effect of food on the bioavailability (how much medication is in your blood) of mebendazole from a single 500 mg oral dose of a fast-disintegrating chewable tablet formulation of mebendazole in healthy adult participants.

Timeline

Start: 2014-02
Primary completion: 2014-04
Completion: 2014-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mebendazole	Small molecule	500 mg	Oral

Indications

No indication recorded.